| P2093 | author name string | Khalid Shah | |
| | Wanlu Du | |
| | Liubov Uslar | |
| | Sindhura Sevala | |
| P2860 | cites work | Met signals hepatocyte survival by preventing Fas-triggered FLIP degradation in a PI3k-Akt-dependent manner. | Q51987719 |
| | cMet and Fas receptor interaction inhibits death-inducing signaling complex formation in endothelial cells. | Q53855934 |
| | How TRAIL kills cancer cells, but not normal cells | Q73632146 |
| | TRAIL: a molecule with multiple receptors and control mechanisms | Q77485552 |
| | The receptor for the cytotoxic ligand TRAIL | Q24310481 |
| | Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product | Q24310794 |
| | Identification and characterization of a new member of the TNF family that induces apoptosis | Q24318423 |
| | Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis | Q24683896 |
| | TRAIL receptor-2 signals apoptosis through FADD and caspase-8 | Q28142998 |
| | Met, metastasis, motility and more | Q28235183 |
| | An antagonist decoy receptor and a death domain-containing receptor for TRAIL | Q28245153 |
| | The TRAIL to selective tumor death | Q28504568 |
| | Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5 | Q30851343 |
| | Evaluating the effect of therapeutic stem cells on TRAIL resistant and sensitive medulloblastomas | Q34474267 |
| | Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. | Q35812718 |
| | c-Met inhibitor synergizes with tumor necrosis factor-related apoptosis-induced ligand to induce papillary thyroid carcinoma cell death | Q35872516 |
| | Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas | Q36695971 |
| | The promise of TRAIL--potential and risks of a novel anticancer therapy | Q36792997 |
| | Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy | Q37140126 |
| | TRAIL on trial: preclinical advances in cancer therapy | Q37433463 |
| | Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors | Q37447217 |
| | Receptor tyrosine kinases: principles and functions in glioma invasion. | Q38033495 |
| | Targeting c-MET in the battle against advanced nonsmall-cell lung cancer | Q38079495 |
| | Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors | Q39198277 |
| | Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma | Q39910399 |
| | Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model | Q39988659 |
| | Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. | Q40476541 |
| | Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. | Q40975748 |
| | A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. | Q43894879 |
| | Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy | Q44198636 |
| | Molecular cloning of a new transforming gene from a chemically transformed human cell line. | Q45345810 |
| | In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis | Q48700301 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain tumor | Q233309 |
| P304 | page(s) | e95490 | |
| P577 | publication date | 2014-04-18 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Targeting c-Met receptor overcomes TRAIL-resistance in brain tumors | |
| P478 | volume | 9 | |